Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 18/20 | 0.53 |
| ▸ | PPARA | Q07869 | 17/20 | 0.52 |
| ▸ | PPARD | Q03181 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5081077 | 0.91 | PPARG (0.63) | PPARGPPARAPPARDLMNATP53 | |
| SCHEMBL7255050 | 0.91 | PPARG (0.63) | PPARGPPARAPPARDLMNATP53 | |
| SCHEMBL14265747 | 0.91 | PPARG (0.63) | PPARGPPARAPPARDLMNATP53 | |
| N-Benzylmethylamine SCHEMBL7524220 | 0.86 | PPARG (0.56) | PPARGPPARAPPARDLMNATP53 | |
| Tromethamine SCHEMBL7525169 | 0.85 | PPARG (0.56) | PPARGPPARAPPARDLMNATP53 | |
| Ammonia Solution, Strong SCHEMBL6283567 | 0.85 | PPARG (0.63) | PPARGPPARAPPARD | |
| SCHEMBL7531698 | 0.84 | PPARG (0.59) | PPARGPPARAPPARD | |
| SCHEMBL7528025 | 0.84 | PPARG (0.53) | PPARGPPARAPPARDLMNATP53 | |
| SCHEMBL5100503 | 0.84 | LMNA (0.54) | PPARGPPARAPPARDLMNATP53 | |
| SCHEMBL14265735 | 0.84 | PPARG (0.54) | PPARGPPARAPPARDLMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020142993-A1 | Pharmaceutically acceptable salts of bicyclic compounds | DR. REDDY'S LABORATORIES LTD. | 2002-10-03 | — | — | US | claimed |
| WO-2002030914-A1 | SALTS OF BENZOTHIAZINE AND BENZOXAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | DR. REDDY'S RESEARCH FOUNDATION (IN) | 2002-04-18 | — | — | WO | claimed |
| US-20020142993-A1 | Pharmaceutically acceptable salts of bicyclic compounds | DR. REDDY'S LABORATORIES LTD. | 2002-10-03 | — | — | US | disclosed |
| WO-2002030914-A1 | SALTS OF BENZOTHIAZINE AND BENZOXAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | DR. REDDY'S RESEARCH FOUNDATION (IN) | 2002-04-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020142993-A1 | Pharmaceutically acceptable salts of bicyclic compounds | CYP3A43, ABCG2, SLC10A1 | PPARG 411/4885PPARA 1234/4885PPARD 471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.